RegentAtlantic Capital’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,393
| Closed | -$10K | – | 702 |
|
|
2022
Q2 | $10K | Buy |
+1,393
| New | +$10K | ﹤0.01% | 675 |
|
|
2021
Q1 | – | Sell |
-213
| Closed | -$24K | – | 558 |
|
|
2020
Q4 | $24K | Hold |
213
| – | – | ﹤0.01% | 499 |
|
|
2020
Q3 | $25K | Hold |
213
| – | – | ﹤0.01% | 487 |
|
|
2020
Q2 | $26K | Buy |
+213
| New | +$26K | ﹤0.01% | 473 |
|